Type 2 Diabetes Trial, Not Yet Recruiting NCT07373392 Sponsor: Aalborg University Condition: Type 2 Diabetes
Back to Type 2 Diabetes

Type 2 Diabetes Trial, Not Yet Recruiting

NCT07373392
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Adults aged 18 or older
  • People who have been found to have prediabetes (slightly raised blood sugar levels) or Type 1 or Type 2 diabetes
  • People with elevated levels of cholesterol or fats (lipids) in their blood, based on specific blood test results
  • People who are either not taking any cholesterol-lowering medication, or who have been on a stable dose of such medication for at least 4 weeks
  • People who are able to swallow capsules and understand Danish
  • People who are willing to keep their usual lifestyle habits and provide stool and blood samples during the trial

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have taken antibiotics in the past 3 months
  • People with very severely elevated triglycerides (a type of blood fat) above 500 mg/dL
  • People with significant liver, kidney, or thyroid disease
  • People who are pregnant or breastfeeding
  • People who have had surgery on their digestive system, or who have a long-term digestive condition such as IBD, IBS, or Crohn's disease
  • People taking long-term medications that affect cholesterol or blood sugar levels, except for certain approved diabetes medications (confirm with trial site)
  • People who have taken part in another clinical trial within the past 3 months
  • People whose capsule intake during the trial falls below 80% of the required amount

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 17 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +45 97663673

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Aalborg University
Registry
ClinicalTrials.gov
Start date
25 January 2026
Est. completion
1 March 2028

Where this trial is recruiting

🇩🇰 Denmark

Primary endpoints

Change in lipid profile (total cholesterol, LDL, HDL, triglycerides)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 17 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov